Diabetes Decision Aid
The American Diabetes Association (ADA) advocates for a shared decision making approach to treating diabetes, particularly as it relates to the numerous pharmacological agents available to patients:
"A patient-centered approach should be used to guide choice of pharmacological agents. Considerations include efficacy, cost, potential side effects, effects on weight, comorbidities, hypoglycemia risk and patient preferences."
Because of this, Janssen Scientific Affairs and Emmi Solutions have partnered to develop a patient decision aid that helps patients, in partnership with their provider, determine the best medication treatment option for their Type 2 Diabetes (T2D).
What Does the Decision Aid Cover?
The Diabetes Medication Options decision aid:
Share the Decision Aid with Your Members or Patients
The Diabetes Medication Options decision aid is free of cost and can be directly embedded on your website, member portal or distributed through other means authorized by Emmi Solutions.
Simply fill out this registration form, and you'll receive full access to the decision aid as well as a toolkit to assist you in communicating the availability of the decision aid to your patients, members and/or physician network.
There is a growing consensus for strengthening the patient's role in managing disease, and we appreciate your commitment to reinforcing this approach with this diabetes decision aid.